Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Diabetes, a disease in which carbohydrate and lipid metabolism are regulated improperly by insulin, is a serious worldwide health issue. Insulin is secreted from pancreatic beta cells in response to elevated plasma glucose, with various factors modifying its secretion. Free fatty acids (FFAs) provide an important energy source as nutrients, and they also act as signalling molecules in various cellular processes, including insulin secretion. Although FFAs are thought to promote insulin secretion in an acute phase, this mechanism is not clearly understood. Here we show that a G-protein-coupled receptor, GPR40, which is abundantly expressed in the pancreas, functions as a receptor for long-chain FFAs. Furthermore, we show that long-chain FFAs amplify glucose-stimulated insulin secretion from pancreatic beta cells by activating GPR40. Our results indicate that GPR40 agonists and/or antagonists show potential for the development of new anti-diabetic drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The binding and subsequent interaction of long-chain FFAs with the G-protein-coupled free fatty acid receptor (FFAR) 1 in the pancreatic β-cells leads to the activation of phospholipase C. PLC then hydrolyzes phosphatidylinositol-4,5-bisphosphate (PIP2) to diacylglycerol and inositol-1,4,5-triphosphate (IP3), with the latter docking on a calcium channel in the endoplasmic reticulum. The subsequent”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [94]
In the citing paper
“Activation of FFAR1 elevates [Ca2+]i and stimulates insulin secretion in a glucose-dependent fashion (306).”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [306]
Citations
Cites
Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas
Lacy, P. E., & Kostianovsky, M. (1967) · Diabetes · doi:10.2337/diab.16.1.35 · Cited by 2,751
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628 · cited 1×
“MAP kinase MAP kinase activation in CHO and MIN6 cells after treatment with 10 µM of each FFA was determined as described previousl”
MethodSelf-citationCloning of the β Cell High-Affinity Sulfonylurea Receptor: a Regulator of Insulin Secretion
Aguilar-Bryan, L., Nichols, C. G., Wechsler, S. W., Clement, J. P., Boyd, A. E., González, G., Herrera-Sosa, H., Nguy, K., Bryan, J., & Nelson, D. A. (1995) · Science · doi:10.1126/science.7716547 · Cited by 1,315
MIYAZAKI, J.-I., ARAKI, K., YAMATO, E., IKEGAMI, H., ASANO, T., SHIBASAKI, Y., OKA, Y., & YAMAMURA, K.-I. (1990) · Endocrinology · doi:10.1210/endo-127-1-126 · Cited by 1,266
Triggering and amplifying pathways of regulation of insulin secretion by glucose.
Henquin, J. C. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1751 · Cited by 1,201 · cited 1×
“Insulin is secreted from pancreatic β cells in response to elevated plasma glucose, with various factors modifying its secretio”
BackgroundThe Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids
Briscoe, C. P., Tadayyon, M., Andrews, J. L., Benson, W. G., Chambers, J. K., Eilert, M. M., Ellis, C., Elshourbagy, N. A., Goetz, A. S., Minnick, D. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211495200 · Cited by 1,104 · cited 1×
“Although it has been reported that FFAs activate GPR40 and that GPR40 is highly expressed in pancreatic β cell”
BackgroundFree Fatty Acids and Pathogenesis of Type 2 Diabetes Mellitus
BERGMAN, R., & ADER, M. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00323-4 · Cited by 622 · cited 1×
“: in short-term exposure, FFAs enhance GSIS but under long-term exposure they act to attenuate it; an effect called lipotoxicit”
BackgroundA prolactin-releasing peptide in the brain
Hinuma, S., Habata, Y., Fujii, R., Kawamata, Y., Hosoya, M., Fukusumi, S., Kitada, C., Masuo, Y., Asano, T., Matsumoto, H., et al. (1998) · Nature · doi:10.1038/30515 · Cited by 563 · cited 1×
“Previously, we established a strategy to identify ligands by detecting signal transductions in cells expressing orphan GPCR”
BackgroundSelf-citationMETABOLIC COUPLING FACTORS IN PANCREATIC β-CELL SIGNAL TRANSDUCTION
Newgard, C. B., & McGarry, J. D. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003353 · Cited by 531 · cited 1×
“Although several studies have proposed possible mechanisms for FFA-amplified GSIS—for example, that FFAs might simply provide energy to β cells or, alternatively, that the metabolites of FFAs, fatty acyl-coenzyme A molecules, act to stimulate insulin secretio”
BackgroundWank, S. A., Harkins, R., Jensen, R. T., Shapira, H., de Weerth, A., & Slattery, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3125 · Cited by 403 · cited 1×
“Its expression was comparable to that of type A cholecystokinin recepto”
Result
Cited by
Items 601–700 of 1,001
Shajith Anoop, S., Dasgupta, R., Rebekah, G. J., Jose, A., Inbakumari, M., Geethanjali, F. S., & Thomas, N. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002414 · Cited by 46
Bartoov-Shifman, R., Ridner, G., Bahar, K., Rubins, N., & Walker, M. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702115200 · Cited by 41
Palmitate-induced Ca2+-signaling in pancreatic beta-cells
Remizov, O., Jakubov, R., Düfer, M., Krippeit Drews, P., Drews, G., Waring, M., Brabant, G., Wienbergen, A., Rustenbeck, I., & Schöfl, C. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.09.026 · Cited by 41
Novel translocation responses of cytosolic phospholipase A2α fluorescent proteins
Wooten, R. E., Willingham, M. C., Daniel, L. W., Leslie, C. C., Rogers, L. C., Sergeant, S., & O’Flaherty, J. T. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.03.008 · Cited by 48
Tanaka, H., Yoshida, S., Minoura, H., Negoro, K., Shimaya, A., Shimokawa, T., & Shibasaki, M. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.11.010 · Cited by 42
“GPR40 is a free fatty acid (FFA) receptor and Gq-coupled G proteincoupled receptor that is highly expressed in pancreatic β-cells and promotes insulin secretion when stimulated by FFAs (Briscoe et al., 2003; Itoh et al., 2003).”
BackgroundSelf-citationQian, J., Wu, C. J., Chen, X., Li, X., Ying, G., Jin, L., Ma, Q., Guo, L., Shi, Y., Zhang, G., et al. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.07.019 · Cited by 48
Mutation analysis and molecular modeling for the investigation of ligand-binding modes of GPR84
Nikaido, Y., Koyama, Y., Yoshikawa, Y., Furuya, T., & Takeda, S. (2014) · The Journal of Biochemistry · doi:10.1093/jb/mvu075 · Cited by 42
Pros and cons of fatty acids in bone biology
Wauquier, F., Léotoing, L., Philippe, C., Spilmont, M., Coxam, V., & Wittrant, Y. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.03.001 · Cited by 46
Mok, H. J., Lee, J. W., Bandu, R., Kang, H. S., Kim, K., & Kim, K. P. (2016) · RSC Advances · doi:10.1039/c6ra01344a · Cited by 45
Islet b cell failure in type 2 diabetes
Prentki, M., & Nolan, C. J. (2006) · Cited by 47
Li, M., Meng, X., Xu, J., Huang, X., Li, H., Li, G., Wang, S., Man, Y., Tang, W., & Li, J. (2016) · Scientific Reports · doi:10.1038/srep25237 · Cited by 43
Nash, A. I. (2016) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2016.07.010 · Cited by 55
Sánchez‐Alegría, K., Bastián‐Eugenio, C. E., Vaca, L. A., & Arias, C. (2021) · The FASEB Journal · doi:10.1096/fj.202100243r · Cited by 45
Gene Silencing in the Endocrine Pancreas Mediated by Short-Interfering RNA
Bradley, S. P., Rastellini, C., da Costa, M. A., Kowalik, T. F., Bloomenthal, A., Brown, M., Cicalese, L., Basadonna, G. P., & Uknis, M. E. (2005) · Pancreas · doi:10.1097/01.mpa.0000179730.69081.64 · Cited by 43
Multitarget PPARγ Agonists as Innovative Modulators of the Metabolic Syndrome
Ammazzalorso, A., Maccallini, C., Amoia, P., & Amoroso, R. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.04.030 · Cited by 39
Oberhauser, L., & Maechler, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010324 · Cited by 43
“The role of FFAR1 (or GPR40) in the acute potentiation of GSIS by exogenous NEFA has been well described [21,88,89].”
BackgroundNakamoto, K., & Tokuyama, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411713 · Cited by 42
Structural basis for the ligand recognition and signaling of free fatty acid receptors
Zhang, X., Guseinov, A.-A., Jenkins, L., Li, K., Tikhonova, I. G., Milligan, G., & Zhang, C. (2024) · Science Advances · doi:10.1126/sciadv.adj2384 · Cited by 45
“FFA1 signaling induced by LCFAs in pancreatic β cells can facilitate insulin secretion ( 6 ), making it a promising drug target for type 2 diabetes mellitus (T2D) ( 7 , 8 ).”
BackgroundSTIM and Orai proteins and the non-capacitative ARC channels
Trevor, J. S. (2011) · Frontiers in bioscience · doi:10.2741/3960 · Cited by 44
“A further complication arises from reports noting that the GPR40 receptor that is abundantly expressed in beta cells, is a Gq/11-protein coupled receptor that is activated by fatty acids, particularly arachidonic acid (81).”
BackgroundMining incretin hormone pathways for novel therapies
Wideman, R. D., & Kieffer, T. J. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.02.005 · Cited by 42
Mao, X.-F., Wu, H., Tang, X.-Q., Ali, U., Liu, H., & Wang, Y. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1457-9 · Cited by 40
Nahon, K. J., Janssen, L. G. M., Sardjoe Mishre, A. S. D., Bilsen, M. P., van der Eijk, J. A., Botani, K., Overduin, L. A., Ruiz, J. R., Burakiewicz, J., Dzyubachyk, O., et al. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14120 · Cited by 37
Discovery of diacylphloroglucinols as a new class of GPR40 (FFAR1) agonists
Bharate, S. B., Rodge, A. H., Joshi, R. K., Kaur, J., Srinivasan, S., Kumar, S., Kulkarni‐Almeida, A., Balachandran, S., Balakrishnan, A., & Vishwakarma, R. A. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.10.085 · Cited by 39
Tran, D. Q., Ramos, E. H., & Belsham, D. D. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.02.019 · Cited by 42
G Protein-Coupled Receptors and Insulin Secretion: 119 and Counting
Madiraju, S. R. M., & Poitout, V. (2007) · Endocrinology · doi:10.1210/en.2007-0336 · Cited by 40
Functional expression of TREK-2 in insulin-secreting MIN6 cells
Kang, D., Choe, C., & Kim, D. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.089 · Cited by 46
Gustducin couples fatty acid receptors to GLP-1 release in colon
Li, Y., Kokrashvili, Z., Mosinger, B., & Margolskee, R. F. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00471.2012 · Cited by 37
“-LA (96 M), a potent agonist for both LCFA receptors GPR40 and GPR120 (28, 34), only slightly increased release of GLP-1 in -gustducin knockout colon tissue (Fig.”
InfluentialThévenod, F. (2008) · Frontiers in diabetes · doi:10.1159/000152019 · Cited by 76
Shi, Y., & Pestka, J. J. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.04.006 · Cited by 38
“Most (>99%) NEFAs bind with albumin to make complexes with the remainder exist as unbound free fatty acid [36] [37] [38] [39].”
BackgroundYechoor, V. K., Liu, V., Paul, A., Lee, J., Buras, E. D., Özer, K., Samson, S. L., & Chan, L. (2009) · Endocrinology · doi:10.1210/en.2009-0527 · Cited by 47
Fan, B., Ikuyama, S., Gu, J.-Q., Wei, P., Oyama, J.-I., Inoguchi, T., & Nishimura, J. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00119.2009 · Cited by 38
Boneva, N. B., Kikuchi, M., Minabe, Y., & Yamashima, T. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10r34fm · Cited by 43
Metabolomics to Explore Impact of Dairy Intake
Zheng, H. X., Clausen, M. R., Dalsgaard, T. K., & Bertram, H. C. (2015) · Nutrients · doi:10.3390/nu7064875 · Cited by 40
“Free fatty acids have been shown to increase insulin secretion from pancreatic β cells by activating G-protein-coupled receptor, GPR40 [36].”
BackgroundKey Questions for Translation of FFA Receptors: From Pharmacology to Medicines
Suckow, A. T., & Briscoe, C. P. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_45 · Cited by 40
Feizi, A., Gatto, F., Uhlén, M., & Nielsen, J. (2017) · npj Systems Biology and Applications · doi:10.1038/s41540-017-0021-4 · Cited by 45
Muredda, L., Kępczyńska, M. A., Zaibi, M. S., Alomar, S. Y., & Trayhurn, P. (2017) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2017.1364774 · Cited by 40
“…of metabolic effects, activation of GPR40, for example, leading to the stimulation of glucose-dependent insulin secretion by pancreatic b cells (Itoh et al. 2003), while activation of GPR43 by short chain fatty acids stimulates the release of leptin from adipocytes and of GLP-1 from colonic…”
BackgroundLiu, D., Costanzo, A., Evans, M. D. M., Archer, N., Nowson, C. A., Duesing, K., & Keast, R. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114518001265 · Cited by 41
“Although FFAR1 was absent in human fungiform papillae, the existence of GPR84 in taste buds of the tongue papillae fills in the gap of the detection of certain MCFA, as some of the agonists overlap between FFAR1 and GPR84(12).”
BackgroundInfluentialUeno, H., Ito, R., Abe, S., Ookawara, M., Miyashita, H., Ogino, H., Miyamoto, Y., Yoshihara, T., Kobayashi, A., Tsujihata, Y., et al. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.255885 · Cited by 42
“Medium-to-long chain fatty acids activate intracellular Ca21 responses in GPR40-expressing cells, demonstrating that they are natural GPR40 ligands (Briscoe et al., 2003; Itoh et al., 2003; Kotarsky et al., 2003).”
BackgroundTrans‐11 vaccenic acid improves insulin secretion in models of type 2 diabetes in vivo and in vitro
Wang, X., Gupta, J., Kerslake, M., Rayat, G. R., Proctor, S. D., & Chan, C. B. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500783 · Cited by 39
Yu, H., Lopez, E., Young, S. W., Luo, J., Tian, H., & Cao, P. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.04.050 · Cited by 40
Label-Free Biosensor Assays in GPCR Screening
Grundmann, M., & Kostenis, E. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2336-6_14 · Cited by 36
Ito, R., Tsujihata, Y., Matsuda‐Nagasumi, K., Mori, I., Negoro, N., & Takeuchi, K. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12297 · Cited by 39
“Indeed, it has been reported that activation of GPR40 by endogenous ligand FFA causes increased ERK1/2 phosphorylation in mouse insulinoma MIN6 cells (Itoh et al., 2003).”
BackgroundRajawat, Y. S., Hilioti, Z., & Bossis, I. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3491 · Cited by 40
“Lipids can affect autophagy indirectly through the insulin=glucagon signaling pathway (12, 16) and cholesterol metabolism (5), or directly, as increased intracellular lipid content was recently shown to impair autophagy (46).”
Doshi, L. S., Brahma, M. K., Sayyed, S. G., Dixit, A. V., Chandak, P. G., Pamidiboina, V., Motiwala, H. F., Sharma, S., & Nemmani, K. V. S. (2009) · Metabolism · doi:10.1016/j.metabol.2008.10.005 · Cited by 44
“Several in vitro and ex vivo studies show that acute stimulation of GPR40 receptor with fatty acids (ie, palmitate, intralipid) potentiates GSIS [7,9,10].”
BackgroundAsano, M., Hong, G., Matsuyama, Y., Wang, W., Izumi, S., Izumi, M., Toda, T., & Kudo, T. (2016) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.238.93 · Cited by 38
“In pancreatic beta cells, where FFAR1 is preferentially expressed, FFAR1 can directly mediate FFA-stimulated insulin secretion (Itoh et al. 2003; Edfalk et al. 2008; Janssen and Depoortere 2013).”
BackgroundChen, C., He, L., & Long, Y. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.10.074 · Cited by 37
Short Chain Fatty Acids, pancreatic dysfunction and type 2 diabetes
Mandaliya, D. K., & Seshadri, S. (2019) · Pancreatology · doi:10.1016/j.pan.2019.04.013 · Cited by 43
Dual effects of the non-esterified fatty acid receptor ‘GPR40’ for human health
Yamashima, T. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.01.002 · Cited by 39
“GPR40 shows higher affinity for longer-chain fatty acids with a half-maximal effective concentration (EC50) in the 1–2 lmol/L range [31,26].”
BackgroundDiscovery of DS-1558: A Potent and Orally Bioavailable GPR40 Agonist
Takano, R., Yoshida, M., Inoue, M., Honda, T., Nakashima, R., Matsumoto, K., Yano, T., Ogata, T., Watanabe, N., Hirouchi, M., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500391n · Cited by 37
Minireview: The Effects of Species Ortholog and SNP Variation on Receptors for Free Fatty Acids
Hudson, B. D., Murdoch, H., & Milligan, G. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1085 · Cited by 37
“First Published Online May 17, 2013 Abbreviations: Arg, arginine; FFA, free fatty acid receptor; GLP-1, glucagon-like peptide-1; GPCR, G protein-coupled receptor; GSIS, glucose stimulated insulin secretion; MAF, minor allele frequency; SCFA, short-chain fatty acid; SNP, single-nucleotide polymorphism.”
InfluentialDysfunctional GPR40/FFAR1 signaling exacerbates pain behavior in mice
Nakamoto, K., Aizawa, F., Miyagi, K., Yamashita, T., Mankura, M., Kōyama, Y., Kasuya, F., Hirasawa, A., Kurihara, T., Miyata, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180610 · Cited by 39
Han, L., Song, S., Niu, Y., Meng, M., & Wang, C. (2017) · Nutrients · doi:10.3390/nu9090937 · Cited by 36
“Long-chain FAs can activate GPR40 [20] and GPR120 [21].”
BackgroundNutrient Sensing via Gut in Drosophila melanogaster
Chopra, G., Kaushik, S., & Kain, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052694 · Cited by 38
“TAS1R2–TAS1R3 [262] Pancreas (β-cells) Potentiation of glucose-induced insulin release by fructose and artificial sweeteners Sweet agonists FFAR1 [263,264] (rodent and human) Pancreas (β-cells) Contradictory findings: potentiation of glucose-induced insulin secretion but also impaired glucose homeostasis Medium-chain…”
BackgroundLau, J., Svensson, J., Grapensparr, L., Johansson, Å., & Carlsson, P. (2012) · Diabetologia · doi:10.1007/s00125-012-2476-6 · Cited by 40
“Gpr40 mediates fatty acid potentiation of glucose-stimulated insulin secretion [36] and can, when overexpressed, augment glucosestimulated insulin secretion [37], possibly by increasing intracellular inositol phosphate levels [38].”
BackgroundManosalva, C., Mena, J., Velásquez, Z. D., Colenso, C. K., Brauchi, S., Burgos, R. A., & Hidalgo, M. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119715 · Cited by 36
“CHO-K1 cells were chosen because they provide stable and accurate posttranslational modification, contain components for typical GPR signaling, and have no endogenous FFAR1 or FFAR3 expression [24,25,26].”
BackgroundMethodInfluentialGraciano, M. F. R., Valle, M. M. R., Curi, R., & Carpinelli, Â. R. (2013) · Islets · doi:10.4161/isl.25459 · Cited by 37
Narita, S., Tsuchiya, N., Saito, M., Inoue, T., Kumazawa, T., Yuasa, T., Nakamura, A., & Habuchi, T. (2008) · The Prostate · doi:10.1002/pros.20681 · Cited by 35
Ou, H., Wu, H., Hung, H., Yang, Y., Wu, J., & Chang, C. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00419.2012 · Cited by 37
“GPR40 couples with a G protein -subunit of the Gq family (12), and its activation in pancreatic islets induces the activity of phospholipase C (PLC) and the hydrolysis of inositol lipids, as well as the intracellular calcium levels (23), and therefore, it increases the secretion of insulin (13, 23).”
BackgroundFurukawa, H., Miyamoto, Y., Hirata, Y., Watanabe, K., Hitomi, Y., Yoshitomi, Y., Aida, J., Noguchi, N., Takakura, N., Takami, K., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00843 · Cited by 35
Liu, T., Ji, R.-L., & Tao, Y.-X. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108044 · Cited by 34
Wang, X., Zhao, T., Yang, B., Li, Z., Cui, J. H., Dai, Y., Qiu, Q., Qiang, H., Huang, W., & Qian, H. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.11.016 · Cited by 35
Verma, M. K., Sadasivuni, M. K., Yateesh, A. N., Neelima, K., Mrudula, S., Reddy, M., Smitha, R., Biswas, S., Chandravanshi, B., Pallavi, P. M., et al. (2014) · BMC Cell Biology · doi:10.1186/1471-2121-15-24 · Cited by 41
“Activation of GPR40 can increase insulin secretion [31-34] through phopsholipase-C (PLC) -Ca pathway only at stimulatory glucose concentration.”
BackgroundLi, Z., Pan, M., Su, X., Dai, Y., Fu, M., Cai, X., Shi, W., Huang, W., & Qian, H. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.03.014 · Cited by 36
Gao, B., Han, Y.-H., Wang, L. Q., Lin, Y.-J., Sun, Z., Lu, W., Hu, Y., Li, J.-Q., Lin, X.-S., Liu, B.-H., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.144 · Cited by 36
“GPR120 and GPR40 are G-protein coupled fatty acid receptors, which are located on the membrane of various cell types and have been implicated in many key cellular processes.(7,19,20) Our”
BackgroundAnti-Inflammatory and Insulin-Sensitizing Effects of Free Fatty Acid Receptors
Miyamoto, J., Kasubuchi, M., Nakajima, A., & Kimura, I. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_47 · Cited by 38
Inducible Pluripotent Stem Cells as a Potential Cure for Diabetes
Verhoeff, K., Henschke, S. J., Marfil-Garza, B. A., Dadheech, N., & Shapiro, A. M. J. (2021) · Cells · doi:10.3390/cells10020278 · Cited by 34
“Similarly, FFA act through the GP40 GPCR to further stimulate insulin release [57,58].”
BackgroundThe role of fatty acids in Crohn's disease pathophysiology – An overview
Piotrowska, M., Binienda, A., & Fichna, J. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111448 · Cited by 37
Zahanich, I., Kondratov, I. S., Naumchyk, V., Kheylik, Y. P., Platonov, M. O., Zozulya, S., & Krasavin, M. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.06.018 · Cited by 34
Jung, Y. H., Lee, S., Oh, S. Y., Lee, H. J., Ryu, J. M., & Han, H. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.05.006 · Cited by 37
Postgenomic characterization of G-protein-coupled receptors
Mertens, I., Vandingenen, A., Meeusen, T., LOOF, A. D., & Schoofs, L. (2004) · Pharmacogenomics · doi:10.1517/14622416.5.6.657 · Cited by 43
Stefanovski, D., Richey, J. M., Woolcott, O., Lottati, M., Zheng, D., Harrison, L. N., Ionut, V., Kim, S. P., Hsu, I., & Bergman, R. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018134 · Cited by 34
“Our group and others have shown significant changes in the nocturnal FFA levels in the insulin resistant or diabetic state [20,13], leading to the hypothesis that perhaps the change in plasma FFA levels, and not plasma glucose, may be the signal for hyperinsulinemic compensation [21,22].”
BackgroundMena, S. J., Manosalva, C., Carretta, M. D., Teuber, S., Olmo, I., Burgos, R. A., & Hidalgo, M. A. (2016) · Innate Immunity · doi:10.1177/1753425916656765 · Cited by 40
“Some reports have suggested the participation of FFAR1/ GPR40 in MAPK and PI3K pathway activation; synthetic and endogenous ligands of FFAR1/GPR40 induce ERK1/2, JNK and p38 MAPK, and PI3K/Akt phosphorylation in b pancreatic cells, breast cancer cells, bovine mammary epithelial cells or murine neurons.(13,15,17,19,20)…”
BackgroundDall, M., Calløe, K., Haupt‐Jorgensen, M., Larsen, J., Schmitt, N., Josefsen, K. E., & Buschard, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066474 · Cited by 33
“We investigated whether the effect of gliadin digest was dependent on two proteins associated with fatty acid-stimulated pathways; GPR40/FFAR1, a fatty acid receptor potentiating insulin secretion [20], and MyD88, a component in TLR2/4 signalling [21].”
BackgroundLi, Z., Liu, C., Xu, X., Qiu, Q., Su, X., Dai, Y., Yang, J., Li, H., Shi, W., Liao, C., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.001 · Cited by 34
Wang, L., Tran, A., Lee, J., & Belsham, D. D. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110991 · Cited by 34
Li, Z., Wang, X., Xu, X., Yang, J., Qiu, Q., Qiang, H., Huang, W., & Qian, H. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.09.010 · Cited by 34
Spexin: Its role, regulation, and therapeutic potential in the hypothalamus
Tran, A., He, W., Chen, J. T. C., & Belsham, D. D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108033 · Cited by 37
Sung, C., Pilla, R., Marsilio, S., Chow, B., Zornow, K. A., Slovak, J. E., Lidbury, J. A., Steiner, J. M., Hill, S. L., & Suchodolski, J. S. (2023) · Animals · doi:10.3390/ani13172753 · Cited by 37
Frangioudakis, G., Gyte, A., Loxham, S. J. G., & Poucher, S. M. (2008) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2007.12.002 · Cited by 33
“More recently, a wide variety of other phenomena have also been implicated in the regulation of GSIS, for example mitochondrial metabolism (Joseph et al., 2006; Kibbey et al., 2007), β-cell lipolysis (Winzell, Strom, Holm & Ahren, 2006), the transcription factor nuclear factor-κB (Norlin, Ahlgren & Edlund, 2005) and t…”
Design and Synthesis of Novel, Selective GPR40 AgoPAMs
Plummer, C. W., Clements, M. J., Chen, H., Rajagopalan, M., Josien, H. B., Hagmann, W. K., Miller, M. D., Trujillo, M. E., Kirkland, M. E., Kosinski, D. T., et al. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00443 · Cited by 33
Grubelnik, V., Markovič, R., Lipovšek, S., Leitinger, G., Gosak, M., Dolenšek, J., Valladolid-Acebes, I., Berggren, P.-O., Stožer, A., Perc, M., et al. (2020) · Royal Society Open Science · doi:10.1098/rsos.191171 · Cited by 32
“The latter has been shown to regulate glucose-induced insulin secretion in pancreatic islets [38].”
BackgroundSabadell‐Basallote, J., Astiarraga, B., Castaño, C., Ejarque, M., Repollés-de-Dalmau, M., Quesada, I., Blanco, J., Núñez‐Roa, C., Rodríguez‐Peña, M., Martínez, L., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci173214 · Cited by 33
“Likewise, other GPCRs, such as GPR40 (activated by free fatty acids), have been reported to use pathways mediated by Gq, PKC, and [Ca 2+ ] i , which are known to trigger insulin secretion (71, 72).”
BackgroundDranse, H. J., Kelly, M. E. M., & Hudson, B. D. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12327 · Cited by 38
“…n-3 FA sensor (Oh et al., 2010), the fact that others have shown similar potencies of n-3 and n-6 FAs at both FFA1 and FFA4 (Briscoe et al., 2003; Itoh et al., 2003; Kotarsky et al., 2003a; Hirasawa et al., 2005), indicates that these effects of n-3 compared with n-6 FAs cannot easily be…”
BackgroundInfluentialFree Fatty Acid Receptor GPR120 and Pathogenesis of Obesity and Type 2 Diabetes Mellitus
Mo, X., Wei, H., Peng, J., & Tao, Y. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-386933-3.00007-8 · Cited by 38
Dixit, V. A., & Bharatam, P. V. (2013) · Journal of Computational Medicine · doi:10.1155/2013/406049 · Cited by 35
“PPARγ modulators or might activate fatty acid receptors on the pancreatic cells (GPR40/FFAR) [138].”
BackgroundHonoré, J., Kooli, A., Hamel, D., Alquier, T., Rivera, J., Quiniou, C., Hou, X., Kermorvant‐Duchemin, E., Hardy, P., Poitout, V., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300943 · Cited by 32
“therapeutic options for the treatment of type 2 diabetes mellitus.(20,22,23) However, the role of GPR40 in brain specifically in HI insult is elusive.”
BackgroundArachidonic acid is a physiological activator of the ryanodine receptor in pancreatic β-cells
Woolcott, O. O., Gustafsson, A. J., Džabić, M., Pierro, C., Tedeschi, P., Sandgren, J., Bari, M. R., Hoa, N. K., Bianchi, M., Rakonjac, M., et al. (2006) · Cell Calcium · doi:10.1016/j.ceca.2006.02.003 · Cited by 36
Fatty acid receptor modulator PBI-4050 inhibits kidney fibrosis and improves glycemic control
Li, Y., Chung, S., Li, Z., Overstreet, J. M., Gagnon, L., Grouix, B., Leduc, M., Laurin, P., Zhang, M., & Harris, R. C. (2018) · JCI Insight · doi:10.1172/jci.insight.120365 · Cited by 33
“It is now recognized that FFAs can activate a family of cell-surface GPCRs.”
BackgroundInfluentialContribution of Mitochondria to Insulin Secretion by Various Secretagogues
Ježek, P., Holendová, B., Jabůrek, M., Dlasková, A., & Plecitá‐Hlavatá, L. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0113 · Cited by 36
“As a result, FASIS should be based on the metabolic components plus metabotropic receptor GPR40 signaling (76, 87, 94, 96, 103, 106, 130, 157, 201, 222, 256, 281, 288).”
BackgroundMethodMacrophage-Mediated Immune Responses: From Fatty Acids to Oxylipins
Balestrieri, B., Costanzo, D. D., & Dwyer, D. F. (2021) · Molecules · doi:10.3390/molecules27010152 · Cited by 36
Molecular mechanism of fatty acid activation of FFAR1
Kumari, P., Inoue, A., Chapman, K., Lian, P., & Rosenbaum, D. M. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2219569120 · Cited by 34
Chapter 9 Nutrient Modulation of Insulin Secretion
Torres, N., Noriega, L. G., & Tovar, A. R. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00609-2 · Cited by 47
Panse, M., Gerst, F., Kaiser, G., Teutsch, C.-A., Dölker, R., Wagner, R. J., Häring, H., & Ullrich, S. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373969 · Cited by 33
Alquier, T., & Poitout, V. (2009) · Diabetes · doi:10.2337/db09-0215 · Cited by 37
“, ileum (1,2), monocytes (1), pancreatic -cells (17), some areas of the brain (1,18), entero-endocrine cells (19), and osteoclasts (20), and its function in these tissues is essentially unknown.”
BackgroundDiscovery of Pyrrolidine-Containing GPR40 Agonists: Stereochemistry Effects a Change in Binding Mode
Jurica, E. A., Wu, X., Williams, K. N., Hernández, A. S., Nirschl, D. S., Rampulla, R., Mathur, A., Zhou, M., Cao, G., Xie, C., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01559 · Cited by 32
Hamdouchi, C., Maiti, P., Warshawsky, A. M., DeBaillie, A. C., Otto, K. A., Wilbur, K. L., Kahl, S. D., Lewis, A. P., Cardona, G. R., Zink, R. W., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01411 · Cited by 32
Ikeda, Y., Iguchi, H., Nakata, M., Ioka, R. X., Tanaka, T., Iwasaki, S., Magoori, K., Takayasu, S., Yamamoto, T. T., Kodama, T., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.005 · Cited by 33
“We screened a library of chemical compounds, including medium and long chain free fatty acids (FFAs) that activate GPR40 (a Gaq-coupled receptor expressed in pancreatic islet) [7,8] and synthetic peptides involved in the regulation of feeding.”
BackgroundTang, C., & Insel, P. A. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.6.1247 · Cited by 32
“GPR40, an orphan GPCR with high level of expression in pancreatic islet β-cells, is activated by long-chain fatty acids [103].”
BackgroundAbaraviciene, S. M., Lundquist, I., Galvanovskis, J., Flodgren, E., Olde, B., & Salehi, A. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002182 · Cited by 37
“the G protein-coupled receptor 40 (GPR40) [4,5,6].”
Vincamine as a GPR40 agonist improves glucose homeostasis in type 2 diabetic mice
Du, T., Yang, L., Xu, X., Shi, X., Xu, X., Lu, J., Lv, J., Huang, X., Chen, J., Wang, H., et al. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0432 · Cited by 32
Metadata
- Authors
- Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., Tanaka, H., Maruyama, M., Satoh, R., Okubo, S., Kizawa, H., Komatsu, H., Matsumura, F., Noguchi, Y., Shinohara, T., Hinuma, S., Fujisawa, Y., & Fujino, M.
- Affiliations
- Takeda (Japan) (JP)
- Corresponding author
- Hinuma, Shuji
- ORCID
- Venue
- Nature
- Published
- 2003-02-23
- Volume
- 422
- Issue
- 6928
- Pages
- 173-176
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2128326754
- Cited by
- 1,538
- References
- 26
- Citations by year
- 2026: 21 · 2025: 50 · 2024: 54 · 2023: 51 · 2022: 58 · 2021: 89 · 2020: 74 · 2019: 75 · 2018: 88 · 2017: 89 · 2016: 111 · 2015: 82 · 2014: 84 · 2013: 91 · 2012: 84
- FWCI
- 45.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- free fatty acids, GPR40, insulin secretion, pancreatic beta cells, glucose-stimulated insulin secretion, long-chain fatty acids, G protein-coupled receptors, diabetes mellitus, antidiabetic drug development
- MeSH terms
- Insulin Secretion, Animals, Haplorhini, Calcium, Enzyme Activation, Fatty Acids, Nonesterified, Glucose, Cricetinae, Humans, Insulin, Male, Molecular Sequence Data, Pancreas, Receptors, Cell Surface, RNA, Messenger, Transfection, CHO Cells, Rats, Wistar, Calcium Signaling, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, RNA, Small Interfering, Receptors, G-Protein-Coupled, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.